Alimera Sciences (ALIM) Misses Q1 EPS by 3c

Alimera Sciences (NASDAQ: ALIM) reported Q1 EPS of ($0.27), $0.03 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Bank of N.T. Butterfield & Son (NTB) Tops Q1 EPS by 20c
• Renasant Corp. (RNST) Tops Q1 EPS by 3c